本文へ移動
電子書籍・電子雑誌Tropical medicine and health
巻号47
Pharmacoki...

Pharmacokinetic analysis of new synthetic antimalarial N-251

記事を表すアイコン
表紙は所蔵館によって異なることがあります ヘルプページへのリンク

Pharmacokinetic analysis of new synthetic antimalarial N-251

国立国会図書館永続的識別子
info:ndljp/pid/11377422
資料種別
記事
著者
Kazuaki Okadaほか
出版者
Springer Nature
出版年
2019-07-05
資料形態
デジタル
掲載誌名
Tropical medicine and health 47(40)
掲載ページ
-
詳細を見る

国立国会図書館での利用に関する注記

本資料は、掲載誌(URI)等のリンク先にある電子書籍・電子雑誌の提供元Webサイトなどから、本文を自由に閲覧できる場合があります。

資料詳細

要約等:

Background<br> With the emergence and growing number of drug-resistant Plasmodium falciparum, a new drug for malaria control must be urgently develope...

全国の図書館の所蔵

国立国会図書館以外の全国の図書館の所蔵状況を表示します。

所蔵のある図書館から取寄せることが可能かなど、資料の利用方法は、ご自身が利用されるお近くの図書館へご相談ください

その他

  • CiNii Research

    検索サービス
    デジタル
    連携先のサイトで、CiNii Researchが連携している機関・データベースの所蔵状況を確認できます。

書誌情報

この資料の詳細や典拠(同じ主題の資料を指すキーワード、著者名)等を確認できます。

デジタル

資料種別
記事
著者・編者
Kazuaki Okada
Akira Sato
Akiko Hiramoto
出版年月日等
2019-07-05
出版年(W3CDTF)
2019-07-05
タイトル(掲載誌)
Tropical medicine and health
巻号年月日等(掲載誌)
47(40)
掲載巻
47(40)
ISSN(掲載誌)
1349-4147
ISSN-L(掲載誌)
1348-8945
本文の言語コード
eng
国立国会図書館永続的識別子
info:ndljp/pid/11377422
コレクション(共通)
コレクション(障害者向け資料:レベル1)
コレクション(個別)
国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
収集根拠
オンライン資料収集制度
受理日(W3CDTF)
2019-10-28T20:45:15+09:00
保存日(W3CDTF)
2019-10-28
記録形式(IMT)
application/pdf
オンライン閲覧公開範囲
国立国会図書館内限定公開
デジタル化資料送信
図書館・個人送信対象外
遠隔複写可否(NDL)
掲載誌(国立国会図書館永続的識別子)
info:ndljp/pid/11285294
連携機関・データベース
国立国会図書館 : 国立国会図書館デジタルコレクション

デジタル

要約等
Background<br> With the emergence and growing number of drug-resistant Plasmodium falciparum, a new drug for malaria control must be urgently developed. The new antimalarial synthetic compound N-251 was recently discovered. As an endoperoxide structure in the body, the compound shows high antimalarial activity and curative effects. We performed a pharmacokinetic (PK) analysis of N-251 under various conditions using mice to understand the inhibitory effect of N-251 in parasite-infected mice.<br> <br> Results<br> PK study of N-251 after intravenous and oral administration in mice showed plasma concentration of N-251 was decreased drastically by intravenous route. Cmax was reached in 2 h after oral administration of N-251, and the level decreased to a level similar to that obtained after intravenous administration. The area under the curves (AUCs) of the plasma concentration of N-251 increased dose-proportionally in both administrations, and bioavailability (F) was approximately 23%. Additionally, Tmax, Cmax, AUC, and F increased in fasted mice compared to normal-fed mice after the administration of N-251, indicating the influence of diet on the absorption kinetics of N-251. Furthermore, in parasite-infected fasted mice, the plasma concentration-time profile of N-251 was similar to that in normal-fasted mice. Based on the PK parameters of single oral administration of N-251, we investigated the effect of multiple oral doses of N-251 (68 mg/kg three times per day for 2 days) in normal-fed mice. The plasma concentration of N-251 was between 10 and 1000 ng/mL. The simulation curve calculated based on the PK parameters obtained from the single-dose study well described the plasma concentrations after multiple oral dosing, indicating that N-251 did not accumulate in the mice. Multiple oral administrations of N-251 in mice were required to completely eliminate parasites without accumulation of N-251.<br> <br> Conclusions<br> N-251 has been selected as a potent antimalarial candidate. We found that N-251 showed short half-life in plasma, and AUCs increased proportionally to dose. With multiple doses of N-251, the plasma level of N-251 was greater than 10 ng/mL in normal-fed mice, and accumulation of N-251 was not observed; however, multiple treatments with N-251 are required for the complete cure of parasite-infected mice. Determining the appropriate dosage was an important step in the clinical applications of N-251.
オンライン閲覧公開範囲
インターネット公開
著作権情報
© The Author(s).
参照
Evaluating the activity of N-89 as an oral antimalarial drug
参照
Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent
Synthesis and Antimalarial Activity of Cyclic Peroxides, 1,2,4,5,7-Pentoxocanes and 1,2,4,5-Tetroxanes
<i>Plasmodium falciparum</i> Endoplasmic Reticulum-Resident Calcium Binding Protein Is a Possible Target of Synthetic Antimalarial Endoperoxides, N-89 and N-251
<i>Qinghaosu</i> (Artemisinin): an Antimalarial Drug from China
Identification of an endoplasmic reticulum-resident calcium-binding protein with multiple EF-hand motifs in asexual stages of Plasmodium falciparum1Note: Nucleotide sequence data reported in this paper have been deposited in the GenBank™ data base with the accession number AF016410.1
Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome
Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol
Stage specific activity of synthetic antimalarial endoperoxides, N-89 and N-251, against Plasmodium falciparum
The global distribution of clinical episodes of Plasmodium falciparum malaria
Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Qinghaosu (Artemisinin): The Price of Success
Synthesis and Antimalarial Activity of Novel Medium-Sized 1,2,4,5-Tetraoxacycloalkanes
The Threat of Artemisinin-Resistant Malaria
Artemisinin Resistance in <i>Plasmodium falciparum</i> Malaria
Medical need, scientific opportunity and the drive for antimalarial drugs
A pharmacokinetics analysis program (MULTI) for microcomputer
連携機関・データベース
国立情報学研究所 : CiNii Research
提供元機関・データベース
学術機関リポジトリデータベース
雑誌記事索引データベース
Crossref
科学研究費助成事業データベース
Crossref
書誌ID(NDLBibID)
11377422